版本:
中国

BRIEF-Insys Therapeutics announces FDA final product label for Syndros

May 24 Insys Therapeutics Inc

* Announces FDA final product label for syndros

* Insys Therapeutics Inc says syndros is approved for use in treating anorexia associated with weight loss in patients with acquired immune deficiency syndrome

* Insys Therapeutics Inc says to launch syndros in August 2017 Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐